Cancer survivors and their supporters celebrate life, raise funds during annual 5K

April 15, 2024

  Misty skies didn’t dampen the spirits of the more than 900 runners and walkers who participated in the 7th annual Give Cancer the Boot Survivorship 5K and 1 Mile Walk on April 6 at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center. Some raised their arms in triumph, others danced, […]




Clinical trial tackles the question of how much treatment is enough for prostate cancer

April 10, 2024

  According to the National Cancer Institute, more than 3 million men are living with prostate cancer in the United States. Of those, survivorship after five years is 97 percent. With patients living longer and physicians seeing younger patients with this type of cancer, learning the best ways to treat patients and providing a better […]




University among top-ranking academic research medical centers

February 22, 2024

  The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio) received $131.5 million in National Institutes of Health funding in federal fiscal year 2023, according to the Blue Ridge Institute for Medical Research. The university ranked No. 72 out of the 2,886 public and private institutions that received […]





UT Health San Antonio becomes first civilian center in South Texas to launch FDA-approved radiotherapy treatment for advanced prostate cancer

October 6, 2023

  The University of Texas Health Science Center at San Antonio (UT Health San Antonio) announces the successful launch of Pluvicto, a radiopharmaceutical used to treat patients with advanced metastatic prostate cancer. Approved by the U.S. Food and Drug Administration in March of 2022, Pluvicto is a novel targeted molecular therapy that delivers radiation treatment […]